Oxidative Stress and Vitamin E Requirements
1 other identifier
interventional
99
1 country
1
Brief Summary
The purpose of this study is to determine if oxidative stress derived from cigarette smoking increases vitamin E requirements. The study will also assess the role of vitamin C in modulating vitamin E requirements. Vitamin E requirements will be assessed by measuring vitamin E in plasma as well as by measuring the excreted vitamin E metabolite in the urine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Sep 2000
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2000
CompletedFirst Submitted
Initial submission to the registry
August 29, 2003
CompletedFirst Posted
Study publicly available on registry
September 8, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2005
CompletedJune 19, 2013
June 1, 2013
5.3 years
August 29, 2003
June 17, 2013
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- non-smoking status or smokers (more than 1 pack per day)
- age: 18-35 y
- stable body weight, ranging between 80% and 130%,
- maintenance of normal exercise and activity patterns
- total cholesterol ≤ 7.758 mmol/L (300 mg/dl)
- triglyceride concentration ≤ 3.387 mmol/L (300 mg/dl)
- Subjects will be excluded if they fulfill any one of the following:
- antioxidant supplement users
- resting blood pressure above 160/105 mm Hg
- engaged in aerobic activity more than five hours per week
- vegetarian or other restrictive dietary requirements
- fasting blood glucose concentration of ≥ 7.77 mmol/L (140 mg/dl)
- history of diabetes or uremia
- other known metabolic disease or medication use known to affect lipid metabolism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Linus Pauling Institute - Oregon State University
Corvallis, Oregon, 97331, United States
Related Publications (3)
Traber MG, Winklhofer-Roob BM, Roob JM, Khoschsorur G, Aigner R, Cross C, Ramakrishnan R, Brigelius-Flohe R. Vitamin E kinetics in smokers and nonsmokers. Free Radic Biol Med. 2001 Dec 1;31(11):1368-74. doi: 10.1016/s0891-5849(01)00723-7.
PMID: 11728808BACKGROUNDDietrich M, Block G, Norkus EP, Hudes M, Traber MG, Cross CE, Packer L. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr. 2003 Jan;77(1):160-6. doi: 10.1093/ajcn/77.1.160.
PMID: 12499336BACKGROUNDTraber MG, van der Vliet A, Reznick AZ, Cross CE. Tobacco-related diseases. Is there a role for antioxidant micronutrient supplementation? Clin Chest Med. 2000 Mar;21(1):173-87, x. doi: 10.1016/s0272-5231(05)70016-2.
PMID: 10763098BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- NIH
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 29, 2003
First Posted
September 8, 2003
Study Start
September 1, 2000
Primary Completion
December 1, 2005
Study Completion
December 1, 2005
Last Updated
June 19, 2013
Record last verified: 2013-06